phase i trial of decitabine plus ipilimumab in r/r mds & aml
Published 3 years ago • 76 plays • Length 1:37
Download video MP4
Download video MP3
Similar videos
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
4:15
phase ib/ii trial of quizartinib, decitabine and venetoclax in flt3-itd-mutated aml
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
4:03
a phase i/ii study evaluating quizartinib plus decitabine and venetoclax in flt3-mutated aml
-
1:27
quizartinib, venetoclax, and decitabine in patients with flt3-itd aml: a phase i/ii trial
-
1:06:04
itp: novel treatments
-
9:16
protrombin time (pt) & activated partial tromboplastin time (aptt)|coagulation analyzer|wila djami
-
12:33
3mensio ct pre-case planning: valve-in-valve tavr in epic/biocor
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
3:13
targeting cd38 with a bispecific antibody to treat r/r aml: a phase i trial
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:39
phase i/ii trial of adct-602 in b-all
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
1:54
fusion-aml-001: molecular changes associated with azacitidine & durvalumab in tp53m aml and hr-mds
-
6:32
a phase i trial of dsp-5336, a novel menin inhibitor, in the treatment of aml
-
5:24
safety by treatment phase and age when treating flt3-itd-mutated aml with quizartinib and chemo
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
3:45
update on phase i trial of teclistamab in r/r myeloma
-
2:41
onvansertib and decitabine in relapsed/refractory aml
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
Clip.africa.com - Privacy-policy